Vimarsana
Biggest News Aggregation in the World

Page 31 - Platform Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Platform Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Platform Technology Today - Breaking & Trending Today

Ericsson technology advances 5G standalone network in Canada - Vimarsana News

Ericsson technology advances 5G standalone network in Canada

/CNW/ -- Marking a major milestone in Canada's evolution to 5G, Ericsson has partnered with Telus to launch and optimize its 5G standalone (5G SA) network from...

"Peptide-nanoparticle conjugates as a theranostic platform" by Suhyeon Kim, Young Hyun No et al. - Vimarsana News

"Peptide-nanoparticle conjugates as a theranostic platform" by Suhyeon Kim, Young Hyun No et al.

Theranostic platforms have emerged as advanced systems integrating diagnostic and therapeutic agents to enable personalized medicine tailored to the specific characteristics of each patient's disease. However, conventional theranostic strategies face challenges in achieving high specificity and sensitivity for diagnosis and therapy. This necessitates the development of novel platforms to improve diagnostic accuracy and therapeutic efficacy. Peptide-nanoparticle conjugates (PNCs) have recently gained attention as promising cancer theranostic platforms, offering enhanced specificity and acc...

Source: uow.edu.au
Sustainable Production and Degradation of Plastics Using Microbes - Vimarsana News

Sustainable Production and Degradation of Plastics Using Microbes

One of the most essential materials in contemporary life is plastic, which is predicted to create 1.23 billion tons by 2060 from an annual production of 460 million tons.

Source: azom.com
Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study - Vimarsana News

Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study

/PRNewswire/ -- Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for the development of...

For Sinoveda, the Proof Is in the Formula - Vimarsana News

For Sinoveda, the Proof Is in the Formula

/PRNewswire/ -- The health and wellness world is filled with potential answers to health challenges. However, many of the current solutions are largely...